|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.10 / 0.19|
Until the indicators offer a clearer picture of where we're headed, stocks will likely swing back and forth for a bit.
The shares' tumble shows how much of a hit a biotech can take at once.
Three once-promising stocks have been hit hard recently, leaving few reasons to believe.
Cramer talks oil, are men really more competative than women, and feng shui's bearish take on the market.
Cramer discusses Ambac Financial, and where do all the market results come from?
Pipex CEO Kanzer takes shareholders down a familiar path.
Activist investor Carl Icahn has nominated three people to the company's board.
ImClone looks even more undervalued than it did three months ago.
A slew of big companies will make presentations at the JPMorgan Healthcare Conference.
Myriad Genetics and Dendreon are among those with major clinical trials next year.
Responding to years of criticism, annual meeting abstracts will now be made available to all.
Gerdau, ImClone, Microsemi and Linn Energy upgraded; Wesco downgraded.
The FDA approves a labeling update for the drug as a treatment for colon cancer.
Large repurchases put Tyco and United Tech on the list.
Fund manager Jim Margard's large-cap picks, the latest insider purchases and a put-selling options play.
Major averages shake off a slew of negatives. Stephen Porpora and Joe Capone handicap what should be a very volatile, dramatic week.
Good news from a number of firms sends shares sharply higher. Chris Edmonds opines on OPEC's surprise, plus Adam Feuerstein on ImClone, Amgen and biotech.
Corcept Pharma climbs on news of an investigational new-drug application from the FDA for Corlux.
Moving its Eribitux drug into lung cancer treatment would spark a jump in profit.
A large phase III study shows the drug prolonging survival in lung cancer patients.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.